{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:31:53Z","timestamp":1790544713082,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T00:00:00Z","timestamp":1540512000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"European Union's Seventh Framework Program","award":["260644-SILVER"],"award-info":[{"award-number":["260644-SILVER"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.antiviral.2018.10.016","type":"journal-article","created":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T03:09:22Z","timestamp":1540436962000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Pyrimethamine inhibits rabies virus replication in vitro"],"prefix":"10.1016","volume":"161","author":[{"given":"Sophie","family":"Rog\u00e9e","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Larrous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9265-6028","authenticated-orcid":false,"given":"Dirk","family":"Jochmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youcef","family":"Ben-Khalifa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Neyts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Bourhy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2018.10.016_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3851\/IMP2851","article-title":"Antiviral therapy for human rabies","volume":"20","author":"Appolinario","year":"2015","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2018.10.016_bib2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.antiviral.2010.02.322","article-title":"Genomics and structure\/function studies of Rhabdoviridae proteins involved in replication and transcription","volume":"87","author":"Assenberg","year":"2010","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.10.016_bib3","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1128\/JVI.01572-14","article-title":"Expression of interferon gamma by a recombinant rabies virus strongly attenuates the pathogenicity of the virus via induction of type I interferon","volume":"89","author":"Barkhouse","year":"2015","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.antiviral.2018.10.016_bib4","doi-asserted-by":"crossref","first-page":"39420","DOI":"10.1038\/srep39420","article-title":"The matrix protein of rabies virus binds to RelAp43 to modulate NF-\u03baB-dependent gene expression related to innate immunity","volume":"21","author":"Ben Khalifa","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2018.10.016_bib5","article-title":"Is there a need for anti-rabies vaccine and immunoglobulins rationing in Europe?","volume":"14","author":"Bourhy","year":"2009","journal-title":"Euro Surveill. Bull. Eur. Sur Mal. Transm. Eur. Commun. Dis. Bull."},{"key":"10.1016\/j.antiviral.2018.10.016_bib6","doi-asserted-by":"crossref","first-page":"e839","DOI":"10.1371\/journal.pntd.0000839","article-title":"Rabies, still neglected after 125 years of vaccination","volume":"4","author":"Bourhy","year":"2010","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.antiviral.2018.10.016_bib7","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1128\/JVI.80.6.2675-2683.2006","article-title":"Inhibition of interferon signaling by rabies virus phosphoprotein P: activation-dependent binding of STAT1 and STAT2","volume":"80","author":"Brz\u00f3zka","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.10.016_bib8","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1128\/JVI.73.1.251-259.1999","article-title":"Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter","volume":"73","author":"Buchholz","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.10.016_bib9","first-page":"33","article-title":"Treatment of rabies in mice and foxes with antiviral compounds","volume":"32","author":"Bussereau","year":"1988","journal-title":"Acta Virol."},{"key":"10.1016\/j.antiviral.2018.10.016_bib10","first-page":"183","article-title":"Pyrimethamine-induced alterations in human lymphocytes in vitro. Mechanisms and reversal of the effect","volume":"93","author":"Bygbjerg","year":"1985","journal-title":"Acta Pathol. Microbiol. Immunol. Scand."},{"key":"10.1016\/j.antiviral.2018.10.016_bib11","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0192-0561(87)90027-0","article-title":"Effect of antimalarial drugs on stimulation and interleukin 2 production of human lymphocytes","volume":"9","author":"Bygbjerg","year":"1987","journal-title":"Int. J. Immunopharm."},{"key":"10.1016\/j.antiviral.2018.10.016_bib12","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1089\/jir.2006.26.271","article-title":"Rabies viral mechanisms to escape the IFN system: the viral protein P interferes with IRF-3, Stat1, and PML nuclear bodies","volume":"26","author":"Chelbi-Alix","year":"2006","journal-title":"J. Interferon Cytokine Res. Off. J. Int. Soc. Interferon Cytokine Res."},{"key":"10.1016\/j.antiviral.2018.10.016_bib13","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1128\/AAC.00397-10","article-title":"Inhibition of dengue virus by an ester prodrug of an adenosine analog","volume":"54","author":"Chen","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2018.10.016_bib14","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s13365-011-0041-6","article-title":"The type I interferon response bridles rabies virus infection and reduces pathogenicity","volume":"17","author":"Chopy","year":"2011","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.antiviral.2018.10.016_bib15","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.antiviral.2018.10.016_bib16","doi-asserted-by":"crossref","first-page":"45871","DOI":"10.1038\/srep45871","article-title":"Herbicidal properties of antimalarial drugs","volume":"7","author":"Corral","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2018.10.016_bib17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.antiviral.2007.10.013","article-title":"The VIZIER project: preparedness against pathogenic RNA viruses","volume":"78","author":"Coutard","year":"2008","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.10.016_bib18","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1038\/82191","article-title":"The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen","volume":"6","author":"Crotty","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2018.10.016_bib19","doi-asserted-by":"crossref","first-page":"e765","DOI":"10.1371\/journal.pntd.0000765","article-title":"More accurate insight into the incidence of human rabies in developing countries through validated laboratory techniques","volume":"4","author":"Dacheux","year":"2010","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"4","key":"10.1016\/j.antiviral.2018.10.016_bib65","doi-asserted-by":"crossref","first-page":"407","DOI":"10.15252\/emmm.201505986","article-title":"Development of broad-spectrum human monoclonal antibodies for rabies post-exposure prophylaxis","volume":"8","author":"De Benedictis","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.antiviral.2018.10.016_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002057","article-title":"Genomic diversity and evolution of the lyssaviruses","volume":"3","author":"Delmas","year":"2008","journal-title":"PloS One"},{"key":"10.1016\/j.antiviral.2018.10.016_bib21","doi-asserted-by":"crossref","first-page":"11915","DOI":"10.1128\/JVI.01207-14","article-title":"Inhibition of enterovirus 71 by adenosine analog NITD008","volume":"88","author":"Deng","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.10.016_bib22","doi-asserted-by":"crossref","first-page":"5027","DOI":"10.1016\/j.vaccine.2009.06.030","article-title":"The fight against rabies in Africa: from recognition to action","volume":"27","author":"Dodet","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2018.10.016_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2017.12.028","article-title":"Mannitol treatment is not effective in therapy of rabies virus infection in mice","author":"Dufkova","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2018.10.016_bib24","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S1473-3099(12)70222-0","article-title":"Malaria prevention in pregnancy, birthweight, and neonatal mortality: a meta-analysis of 32 national cross-sectional datasets in Africa","volume":"12","author":"Eisele","year":"2012","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.antiviral.2018.10.016_bib25","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1016\/S2214-109X(14)70385-7","article-title":"Cost-effectiveness of two versus three or more doses of intermittent preventive treatment for malaria during pregnancy in sub-Saharan Africa: a modelling study of meta-analysis and cost data","volume":"3","author":"Fernandes","year":"2015","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.antiviral.2018.10.016_bib26","doi-asserted-by":"crossref","first-page":"17091","DOI":"10.1038\/nrdp.2017.91","article-title":"Rabies","volume":"3","author":"Fooks","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.antiviral.2018.10.016_bib27","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1128\/AAC.01717-10","article-title":"Induction of antimalaria immunity by pyrimethamine prophylaxis during exposure to sporozoites is curtailed by parasite resistance","volume":"55","author":"Friesen","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2018.10.016_bib28","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejcb.2011.01.008","article-title":"Significantly improved rescue of rabies virus from cDNA plasmids","volume":"91","author":"Ghanem","year":"2012","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.antiviral.2018.10.016_bib29","article-title":"Estimating the global burden of endemic canine rabies","volume":"9","author":"Hampson","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.antiviral.2018.10.016_bib30","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/13550280600902295","article-title":"Failure of therapeutic coma and ketamine for therapy of human rabies","volume":"12","author":"Hemachudha","year":"2006","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.antiviral.2018.10.016_bib31","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2174\/138945007779315524","article-title":"Targeting purine and pyrimidine metabolism in human apicomplexan parasites","volume":"8","author":"Hyde","year":"2007","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.antiviral.2018.10.016_bib32","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.antiviral.2013.01.003","article-title":"Current and future approaches to the therapy of human rabies","volume":"99","author":"Jackson","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.10.016_bib33","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.antiviral.2012.06.005","article-title":"Is minocycline useful for therapy of acute viral encephalitis?","volume":"95","author":"Jackson","year":"2012","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.10.016_bib34","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nprot.2006.53","article-title":"High-efficiency transfection and drug selection of genetically transformed blood stages of the rodent malaria parasite Plasmodium berghei","volume":"1","author":"Janse","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.antiviral.2018.10.016_bib35","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1001\/jama.2012.216231","article-title":"Intermittent preventive therapy for malaria during pregnancy using 2 vs 3 or more doses of sulfadoxine-pyrimethamine and risk of low birth weight in Africa: systematic review and meta-analysis","volume":"309","author":"Kayentao","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.antiviral.2018.10.016_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003678","article-title":"Inhibition of pyrimidine biosynthesis pathway suppresses viral growth through innate immunity","volume":"9","author":"Lucas-Hourani","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2018.10.016_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2018.05.066","article-title":"Combination therapy of rabies-infected mice with inhibitors of pro-inflammatory host response, antiviral compounds and human rabies immunoglobulin","author":"Marosi","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2018.10.016_bib38","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1128\/AAC.36.5.1040","article-title":"Levels of pyrimethamine in sera and cerebrospinal and ventricular fluids from infants treated for congenital toxoplasmosis. toxoplasmosis study group","volume":"36","author":"McLeod","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2018.10.016_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2018.02.057","article-title":"In vitro and in vivo evaluation of a single chain antibody fragment generated in planta with potent rabies neutralisation activity","author":"Phoolcharoen","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2018.10.016_bib41","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.3201\/eid2207.151733","article-title":"Travel-associated rabies in pets and residual rabies risk, Western Europe","volume":"22","author":"Ribadeau-Dumas","year":"2016","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2018.10.016_bib42","article-title":"Fatal case of imported human rabies in Amadora, Portugal, August 2011","volume":"17","author":"Santos","year":"2012","journal-title":"Euro Surveill. Bull. Eur. Sur Mal. Transm. Eur. Commun. Dis. Bull."},{"key":"10.1016\/j.antiviral.2018.10.016_bib43","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/B978-0-12-387040-7.00013-5","article-title":"Postexposure prophylaxis for rabies in resource-limited\/poor countries","volume":"79","author":"Shantavasinkul","year":"2011","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.antiviral.2018.10.016_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2018.04.003","article-title":"The effect of combined drugs therapy on the course of clinical rabies infection in a murine model","author":"Smreczak","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2018.10.016_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027866","article-title":"Ribavirin enhances IFN-\u03b1 signalling and MxA expression: a novel immune modulation mechanism during treatment of HCV","volume":"6","author":"Stevenson","year":"2011","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.antiviral.2018.10.016_bib66","first-page":"69","article-title":"Effect of amantadine on rhabdovirus infection","volume":"11","author":"Superti","year":"1985","journal-title":"Drugs Exp. Clin. Res."},{"key":"10.1016\/j.antiviral.2018.10.016_bib46","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1093\/hmg\/ddr338","article-title":"Pyrimethamine inhibits adult polycystic kidney disease by modulating STAT signaling pathways","volume":"20","author":"Takakura","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.antiviral.2018.10.016_bib47","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1177\/095632020101200501","article-title":"Mechanisms of action of ribavirin in antiviral therapies","volume":"12","author":"Tam","year":"2001","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.antiviral.2018.10.016_bib48","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1001\/jama.297.23.2603","article-title":"Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review","volume":"297","author":"Ter Kuile","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.antiviral.2018.10.016_bib49","first-page":"129","article-title":"Monoclonal antibody studies of rabies viruses isolated from Thailand","volume":"21","author":"Thongcharoen","year":"1990","journal-title":"Southeast Asian J. Trop. Med. Public Health"},{"key":"10.1016\/j.antiviral.2018.10.016_bib50","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1093\/infdis\/jis025","article-title":"Ribavirin regulates hepatitis C virus replication through enhancing interferon-stimulated genes and interleukin 8","volume":"205","author":"Tokumoto","year":"2012","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2018.10.016_bib51","doi-asserted-by":"crossref","first-page":"e460","DOI":"10.1016\/S2214-109X(14)70256-6","article-title":"Estimated risk of placental infection and low birthweight attributable to Plasmodium falciparum malaria in Africa in 2010: a modelling study","volume":"2","author":"Walker","year":"2014","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.antiviral.2018.10.016_bib52","doi-asserted-by":"crossref","first-page":"12554","DOI":"10.1128\/JVI.79.19.12554-12565.2005","article-title":"Attenuated rabies virus activates, while pathogenic rabies virus evades, the host innate immune responses in the central nervous system","volume":"79","author":"Wang","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.10.016_bib53","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/bmj.299.6703.830","article-title":"Failure of interferon alfa and tribavirin in rabies encephalitis","volume":"299","author":"Warrell","year":"1989","journal-title":"BMJ"},{"key":"10.1016\/j.antiviral.2018.10.016_bib54","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1093\/infdis\/157.3.580","article-title":"Pyrimethamine concentrations in serum and cerebrospinal fluid during treatment of acute Toxoplasma encephalitis in patients with AIDS","volume":"157","author":"Weiss","year":"1988","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2018.10.016_bib55","series-title":"Human rabies: 2016 updates and call for data","author":"WHO","year":"2017"},{"key":"10.1016\/j.antiviral.2018.10.016_bib56","unstructured":"WHO Rabies vaccines: 2018 WHO position paper \u2013 April 2018 WHO URl http:\/\/origin.who.int\/rabies\/resources\/who_wer9316\/en\/(accessed 4.20.2018)."},{"key":"10.1016\/j.antiviral.2018.10.016_bib57","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/B978-0-12-387040-7.00021-4","article-title":"Rabies research in resource-poor countries","volume":"79","author":"Wilde","year":"2011","journal-title":"Adv. Virus Res."},{"issue":"12","key":"10.1016\/j.antiviral.2018.10.016_bib67","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/01.inf.0000191443.48828.79","article-title":"Prophylaxis against rabies in children exposed to bats","volume":"24","author":"Willoughby","year":"2005","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.antiviral.2018.10.016_bib58","doi-asserted-by":"crossref","first-page":"10194","DOI":"10.1128\/JVI.01249-12","article-title":"Conservation of a unique mechanism of immune evasion across the Lyssavirus genus","volume":"86","author":"Wiltzer","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.10.016_bib59","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1093\/infdis\/jiv586","article-title":"Efficacy of Favipiravir (T-705) in rabies postexposure prophylaxis","volume":"213","author":"Yamada","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2018.10.016_bib60","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/jcb.20657","article-title":"C-type natriuretic peptide enhances osteogenic protein-1-induced osteoblastic cell differentiation via Smad5 phosphorylation","volume":"97","author":"Yeh","year":"2006","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.antiviral.2018.10.016_bib61","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1128\/AAC.04779-14","article-title":"Synergistic suppression of dengue virus replication using a combination of nucleoside analogs and nucleoside synthesis inhibitors","volume":"59","author":"Yeo","year":"2015","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354218303371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354218303371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,14]],"date-time":"2020-11-14T00:59:17Z","timestamp":1605315557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354218303371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":63,"alternative-id":["S0166354218303371"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2018.10.016","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pyrimethamine inhibits rabies virus replication in vitro","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2018.10.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}